Related Experiment Video
Updated: Dec 25, 2025
11:02
Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
23.7K
Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.
Huan Lin1, Wenting Wang1, Madeline Lee2
1Department of Intensive Care Unit, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Frontiers in Pharmacology
|March 21, 2020
Summary
Septic cardiomyopathy (SCM), a sepsis-induced heart failure, lacks clear diagnostic criteria. This review summarizes recent findings on SCM pathogenesis, diagnosis, and treatment to advance understanding and patient care.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Septic cardiomyopathy (SCM) is a critical complication of sepsis, characterized by cardiovascular dysfunction.
- Despite advancements, consistent diagnostic criteria for SCM remain elusive.
- Understanding SCM's pathophysiology is crucial for effective management.
Purpose of the Study:
- To review recent literature (past 5 years) on septic cardiomyopathy.
- To provide an overview of current knowledge regarding SCM pathogenesis.
- To summarize contemporary diagnostic and therapeutic strategies for SCM.
Main Methods:
- Systematic literature search of major scientific databases.
- Inclusion of studies published within the last five years.
- Synthesis of data on SCM pathogenesis, diagnosis, and treatment.
Main Results:
- Several hypotheses on the pathogenic mechanisms of SCM have been proposed.
- Progress has been made in diagnostic approaches, though standardization is lacking.
- Current treatment strategies are evolving based on emerging pathophysiological insights.
Conclusions:
- Septic cardiomyopathy presents a complex challenge in sepsis management.
- Further research is needed to refine diagnostic criteria and therapeutic interventions for SCM.
- A comprehensive understanding of SCM pathogenesis is essential for improving outcomes.
Keywords:
diagnosisheart failureleft ventricular ejection fractionpathogenesissepsisseptic cardiomyopathytreatmentMore Related Videos
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
17.7K
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
8.0K
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
237
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
237
01:25Cardiomyopathy I: Introduction and Classification
415
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
415
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
289
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
289
01:30Cardiomyopathy II: Dilated Cardiomyopathy
350
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
350
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
370
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
370
01:29Cardiomyopathy VI: Nursing Management
233
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
233